Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma

12 Oct 2022

Abstract excerpt

Glaucoma is the main cause of irreversible visual loss worldwide, and comprises a group of progressive, age-related, and chronic optic neuropathies. Prostaglandin analogs are considered a first-line treatment in the management of glaucoma and have the best efficacy in reducing intraocular pressure. When comparing these therapeutic agents between them, long-term therapy with 0.03% bimatoprost is the most effective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glaucoma and retinal disorders
Share to Retinal Diseases and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36313286
DOI: 10.3389/fphar.2022.1015338

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucomaPMID 36313286Read ↗

Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients.Semantic proximity Read ↗

Glaucoma diagnosis and treatment in the era of precision medicine.Semantic proximity Read ↗

Evaluation of ADRB2 and OATP2A1 genetic polymorphisms in Indian patients with primary open-angle glaucoma.Semantic proximity Read ↗

Correlations of AFAP1, GMDS and PTGFR gene polymorphisms with intra-ocular pressure response to latanoprost in patients with primary open-angle glaucoma.Semantic proximity Read ↗

Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Recent patents and developments in glaucoma biomarkers.Semantic proximity Read ↗

Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients.Semantic proximity Read ↗

<i>PTGFR</i> and <i>SLCO2A1</i> Gene Polymorphisms Determine Intraocular Pressure Response to Latanoprost in Han Chinese Patients with GlaucomaSemantic proximity Read ↗

Pharmacogenomics in ophthalmology.Semantic proximity Read ↗

Association between SNPs of Metalloproteinases and Prostaglandin F2α Receptor Genes and Latanoprost Response in Open-Angle Glaucoma.Semantic proximity Read ↗

Lack of association between polymorphisms in the prostaglandin F2α receptor and solute carrier organic anion transporter family 2A1 genes and intraocular pressure response to prostaglandin analogs.Semantic proximity Read ↗

Identifying Diagnostic Biomarkers for Glaucoma Based on Transcriptome Combined with Mendelian RandomizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.